Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.
Journal of Urology.
Times cited: 121
Risk Stratification for Bladder Tumor Recurrence, Stage and Grade by Urinary Nuclear Matrix Protein 22 and Cytology.
Times cited: 40
Urinary Levels of Urokinase-Type Plasminogen Activator and Its Receptor in the Detection of Bladder Carcinoma  (multiple letters).
Times cited: 2